Ankylosing Spondylitis Clinical Trials

A listing of Ankylosing Spondylitis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

UPDATED

Birmingham Alabama

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

UPDATED

Tucaloosa Alabama

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

Arizona

UPDATED

Glendale Arizona

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

UPDATED

Mesa Arizona

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

UPDATED

Phoenix Arizona

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

UPDATED

Sun City Arizona

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

Arkansas

UPDATED

Little Rock Arkansas

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

California

UPDATED

Palm Desert California

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

UPDATED

Palm Desert California

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

UPDATED

San Francisco California

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

UPDATED

Tustin California

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

UPDATED

Upland California

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

View More ▼

La Jolla California 92093-0828

OTIS Autoimmune Diseases in Pregnancy Project

San Diego California 92093

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease or Rheumatoid Arthritis

Colorado

UPDATED

Denver Colorado

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

Florida

UPDATED

Brandon Florida

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

UPDATED

Daytona Beach Florida

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

UPDATED

Debary Florida

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

UPDATED

Fort Lauderdale Florida

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

UPDATED

New Port Richey Florida

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

View More ▼

UPDATED

Orlando Florida

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

UPDATED

Plantation Florida

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

UPDATED

Tampa Florida

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

UPDATED

Vero Beach Florida

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

St. Petersburg Florida

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

Tampa Florida

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

Georgia

CSI Research Inc
Alpharetta Georgia 30022

A Phase III, randomized, double-blind, placebo-controlled trial in patients with Ankylosing Spondylitis (AS).

Idaho

UPDATED

Idaho Falls Idaho

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

Louisiana

Monroe Louisiana

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

Maryland

The Center for Rheumatology and Bone Research
Wheaton Maryland 20902

A randomized double blind placebo controlled dose ranging study to evaluate the efficacy and safety of IL-6Ra mAb in patients with Ankylosing Spondylitis

View More ▼

UPDATED

Cumberland Maryland

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

UPDATED

Cumberland Maryland

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

UPDATED

Hagerstown Maryland

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

UPDATED

Wheaton Maryland

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

Minnesota

UPDATED

Eagan Minnesota

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

Eagan Minnesota

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

Missouri

UPDATED

St. Louis Missouri

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

New York

New York New York 10021

Patients are needed to participate in a clinical research study for the treatment of Spondyloarthritis

Orchard Park New York

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

North Carolina

UPDATED

Charlotte North Carolina

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

North Dakota

UPDATED

Minot North Dakota

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

Pennsylvania

UPDATED

Duncansville Pennsylvania

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

UPDATED

Duncansville Pennsylvania

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

UPDATED

West Reading Pennsylvania

Patients are needed to participate in a clinical research study of Certolizumab Pegol and Placebo to evaluate Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis or Nr-axSpA

Duncansville Pennsylvania

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

Wyomissing Pennsylvania

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

Tennessee

UPDATED

Jackson Tennessee

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis

Jackson Tennessee

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

Texas

UPDATED

Austin Texas

A clinical research study of Certolizumab Pegol and Placebo for the treatment of Axial Spondyloarthrithis or Ankylosing Spondylitis